Jove
Visualize
Contact Us

Related Concept Videos

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

1.6K
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
1.6K
Drugs Used in Upper Respiratory Disorders: Overview01:16

Drugs Used in Upper Respiratory Disorders: Overview

983
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
983
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

1.5K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.5K
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

3.3K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
3.3K
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

1.1K
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
1.1K
Upper Respiratory Drugs: Decongestants01:27

Upper Respiratory Drugs: Decongestants

1.3K
Decongestants are a class of medications used primarily to alleviate nasal congestion, a common symptom resulting from allergies, colds, sinusitis, and other upper respiratory tract infections. These drugs work by activating α-adrenergic receptors, constricting small blood vessels in the nasal membranes. This action results in the opening of clogged nasal passages, thereby facilitating sinus drainage and relieving congestion.
Most decongestants are readily available over-the-counter in...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cross-country skiers often experience respiratory symptoms during and after exercise but have a low prevalence of prolonged cough.

BMJ open sport & exercise medicine·2023
Same author

β2-Adrenoceptor Agonists in Asthma or Chronic Obstructive Pulmonary Disease and Risk of Parkinson's Disease: Nested Case-Control Study.

Clinical epidemiology·2023
Same author

Reticulation pattern without honeycombing on high-resolution CT is associated with the risk of disease progression in interstitial lung diseases.

BMC pulmonary medicine·2022
Same author

Risk factors of clinically significant complications in transbronchial lung cryobiopsy: A prospective multi-center study.

Respiratory medicine·2022
Same author

Nurses´ perceptions of automated dispensing cabinets - an observational study and an online survey.

BMC nursing·2020
Same author

Opioid-Induced Bowel Dysfunction in Patients Undergoing Spine Surgery: Comparison of Oxycodone and Oxycodone-Naloxone Treatment.

Advances in therapy·2016
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Mar 22, 2026

Methods for Detecting Cough and Airway Inflammation in Mice
04:33

Methods for Detecting Cough and Airway Inflammation in Mice

Published on: August 2, 2024

1.5K

[Drug therapy for cough].

Heikki Koskela, Toivo Naaranlahti

    Duodecim; Laaketieteellinen Aikakauskirja
    |April 20, 2016
    PubMed
    Summary

    Effective cough treatment often involves addressing underlying conditions like asthma. When the cause is unclear or standard treatments fail, targeted drug therapies such as honey, menthol, antihistamines, or receptor blockers offer alternative solutions.

    Area of Science:

    • Pharmacology and Therapeutics
    • Respiratory Medicine

    Background:

    • Cough therapy often necessitates identifying and treating the root cause, such as asthma.
    • In many cases, an underlying disease is not identified, or conventional treatments prove ineffective for cough relief.

    Purpose of the Study:

    • To explore drug therapy options for cough when underlying diseases are not found or conventional treatments fail.
    • To provide guidance on selecting appropriate medications based on the suspected cause of persistent cough.

    Main Methods:

    • Review of pharmacological interventions for various cough etiologies.
    • Categorization of drug recommendations based on associated conditions (respiratory infections, allergic rhinitis, asthma, malignant disease, idiopathic cough).

    Main Results:

    More Related Videos

    Establishment of a Mouse Model with Cough Hypersensitivity via Inhalation of Citric Acid
    05:43

    Establishment of a Mouse Model with Cough Hypersensitivity via Inhalation of Citric Acid

    Published on: January 10, 2025

    1.4K
    Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment
    03:25

    Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment

    Published on: December 27, 2024

    1.8K

    Related Experiment Videos

    Last Updated: Mar 22, 2026

    Methods for Detecting Cough and Airway Inflammation in Mice
    04:33

    Methods for Detecting Cough and Airway Inflammation in Mice

    Published on: August 2, 2024

    1.5K
    Establishment of a Mouse Model with Cough Hypersensitivity via Inhalation of Citric Acid
    05:43

    Establishment of a Mouse Model with Cough Hypersensitivity via Inhalation of Citric Acid

    Published on: January 10, 2025

    1.4K
    Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment
    03:25

    Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment

    Published on: December 27, 2024

    1.8K
    • Specific drug classes are recommended for different cough types: honey/menthol for infections, antihistamines for allergic rhinitis, leukotriene/muscarinic receptor blockers for asthma-associated cough, and morphine for malignant disease-related cough.
    • Menthol, muscarinic receptor blockers, or dextromethorphan are suggested for prolonged idiopathic cough.
    • Codeine is deemed unnecessary for cough treatment, and non-drug interventions should be considered.

    Conclusions:

    • Targeted pharmacotherapy provides viable options for managing cough when underlying causes are elusive or resistant to standard care.
    • Treatment selection should be guided by the specific clinical context and suspected etiology of the cough.
    • Non-pharmacological approaches and judicious use of medications, avoiding unnecessary drugs like codeine, are emphasized.